SlideShare a Scribd company logo
WARD ROUND PARTICIPATION
AMEENA KADAR K A
FIRST SEM M PHARM
PHARMACY PRACTICE
SANJO COLLEGE OF PHARMACEUTICAL STUDIES
CLINICAL PHARMACY SERVICES
MEDICAL WARD ROUNDS
 Ward rounds are the routine clinical rounds where the
healthcare professionals (a doctor with or without a nurse,
pharmacist, or any paramedical staff like technician or
physiotherapist) visit the patients in the ward to assess the
progress of the health condition of the inpatients.
 At least one ward round is conducted every day to review the
progress of each inpatient, although more than one is not
uncommon.
 It is also utilized as bedside teaching skills in a teaching hospital.
Goals and Objectives of Clinical Pharmacists on Ward
Rounds
• Gain an improved understanding of the patient’s clinical status and
progress, current planned investigations and therapeutic goals.
• Provide relevant information on various aspects of the patient’s
drug therapy, such as pharmacology, pharmacokinetics, drug
availability, cost, drug interactions and adverse reactions
• Optimize therapeutic management by influencing drug therapy
selection, implementation, monitoring and follow-up
• Investigate unusual drug orders or doses
• Assimilate additional information about the patient such as
comorbidities, medication compliance or complementary and
alternative medicine (for example herbal remedies) use that might be
relevant to their management
• Detect adverse drug reactions and drug interactions
• Participate in patient discharge planning.
WARD ROUND CLASSIFICATION
1. Pre-ward rounds.
2. Registrar/resident rounds.
3. Professor/chief rounds.
4. Teaching ward rounds.
PRE-ROUNDS
 During these rounds, the interns or medical post-graduate
students in teaching hospitals perform a daily review of patients
in their unit or ward.
 This is largely a learning opportunity to familiarize themselves
with the cases, especially new admissions or transfers, and very
few management decisions are made during these rounds.
 Trainee clinical pharmacists may join the interns or
postgraduates in their pre-rounds and complete the patient
medication and clinical review at this time.
REGISTRAR/RESIDENT ROUNDS
 In teaching hospitals, the registrars and residents, individually or
as a team conduct ward rounds, at least once a day at a fixed
time, usually in the morning.
 In the intensive care unit (ICU), rounds may be conducted several
times a day.
 These rounds are extensive and may also involve clinical
teaching to medical postgraduate students and interns.
 These are useful rounds for clinical pharmacists of all levels too.
PROFESSOR/UNIT CHIEF ROUNDS
 A ward round participation involving PG students, registrars,
residents, and experienced doctors together is known as
professor/chief rounds. It may be conducted daily, weekly, or
monthly.
 These types of ward rounds become extensive and specialized
for discussing complex and complicated problems.
 It may be difficult for clinical pharmacists to join these
consultant rounds due to timing.
TEACHING ROUNDS
 In teaching hospitals, academic medical staff conducts bedside
clinical teaching rounds for residents, medical PG students,
interns, medical UG students, and Pharm D students.
 It is usually extensive rounds and is conducted only a few times
a week.
 A clinical pharmacist can join during such rounds but will have
limited exposure since this kind of ward rounds do not involve
any kind of decision making and interventions.
PRE-WARD ROUND PREPARATION
• Pharmacists need to prepare adequately before participating in
ward rounds.
• Accurate and up to date information on the patient’s health
status, disease management and past medical history is essential
for effective participation in clinical decision making.
• To achieve this a review of the medication chart and case record
should be completed prior to the ward round.
• Pre-ward round participation gives an overview of the drug and
disease related issues that may arise during a ward round.
 Many clinical pharmacists maintain individual patient profiles
which summarize information relevant to the patient’s drug
therapy. This includes:
 Allergies or hypersensitivities
 The reason for admission
 Provisional or final diagnosis
 Past medical history
 Medications on admission
 Relevant social history
 laboratory data
 Other relevant investigations and reports
 Medication compliance
Patient Profile Form
 For all newly admitted patients, it is appropriate to collect a
detailed medication history from the patient or their carers,
which needs to be cross-checked with information collected by
other healthcare professionals.
 Any relevant new information obtained during the medication
history interview which may change patient management (for
example, history of allergy to a medicine) should be brought to
the attention of the appropriate healthcare professionals and
used to update existing patient profiles.
 Pre-ward round preparation allows the pharmacist to be well
informed and organized about the patient.
Practical tips for ward round participation
 Pharmacists should complete their pre-ward round preparation
well ahead of commencement of the round.
 Pharmacist should ensure that all prescriptions are in
accordance with the hospital formulary.
 Clinical pharmacists may wish to carry appropriate references
while working in wards, Eg. BNF, up-to-date clinical
guidelines, Drug Information Books., etc.
 When identifying potential problems such as drug interactions,
adverse reactions and medication errors, pharmacists should be
prepared to suggest alternatives to resolve the problem.
 Pharmacists should avoid the temptation to enter discussions
concerning diagnosis. The one exception to this is where a
patient’s symptoms or signs are possibly drug-related.
Interventions during ward rounds
A pharmacist intervention is defined as any action by a pharmacist
that directly results in a change in patient management or therapy.
Types:
i. Active - Personal visits to influence prescribing
ii. Passive - Drug information services
iii. Reactive - Monitoring prescriptions
The errors identified by the pharmacist included:
o Incomplete orders
o Wrong dose
o Wrong frequency
o Inappropriate choice
o Duplicate therapy.
The main drug-related queries that may arise during ward rounds
relate to:
 Dose and frequency
 choice of medication
 Adverse effects
 Drug interactions
 Formulation
 Duration of therapy
 Actions and uses/pharmacology
 Drug availability/supply
 Identification of patient’s medications on admission
 legal and administrative issues
 Miscellaneous, such as storage conditions
Communication during ward rounds
 Effective communication skills and clinical knowledge are pre-
requisites for effective participation ward rounds.
 Good interpersonal relationships are a key of success.
 Learning of regional language helps the pharmacist to follow
the conversation between the clinicians and the patients.
 It also helps you to interact effectively with the patients.
 Interventions or recommendations made by the pharmacist
should be made in a diplomatic way, which shows respect for the
physician’s clinical acumen and experience, and should not
challenge a medical practitioner’s integrity.
WARD ROUND FOLLOW-UP
 Clinical pharmacists often encounter issues during a ward round
that require some follow-up.
 Some of the outstanding issues that may arise during a ward
round include:
1. Responding to enquiries
2. Communicating information - changes in drug therapy
3. Completing documentation-ADRs identified during the
round may need to be documented on an alert sheet.
4. Altering the patient’s care plan
5. Discussions with patients - the reasons for alteration in
therapy, drug administration or self monitoring techniques
and caution regarding likely adverse effects
REFERENCES
1. A Textbook of Clinical Pharmacy, Essential concepts and
Skills by G Parthasarathy, Karin Nyfort-Hansen, Milap C
Nahata. 2nd Edition. Pg No:211- 221.
2. https://www.14impressions.in/2020/12/goals-
classification-interventions-and.html#point0
HAVE A GOOD DAY!

More Related Content

What's hot

Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
Rafi Bhat
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
KRUSHNA ZAMBARE
 
14ab1t0012 dispensing of narcotics and controlled substances
14ab1t0012   dispensing of narcotics and controlled substances14ab1t0012   dispensing of narcotics and controlled substances
14ab1t0012 dispensing of narcotics and controlled substances
Ramesh Ganpisetti
 
14ab1 t0011 professional relations and practices of hospital pharmacy
14ab1 t0011  professional relations and practices of hospital pharmacy14ab1 t0011  professional relations and practices of hospital pharmacy
14ab1 t0011 professional relations and practices of hospital pharmacy
Ramesh Ganpisetti
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
Sitaram Khadka
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
Sohan Patel
 
14ab1t0020 pharmacy and therapeutic committee
14ab1t0020   pharmacy and therapeutic committee14ab1t0020   pharmacy and therapeutic committee
14ab1t0020 pharmacy and therapeutic committee
Ramesh Ganpisetti
 
Drug information final
Drug information finalDrug information final
Drug information final
Sitaram Khadka
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
APOLLO JAMES
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
Subhash Yende
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
Dr. Ramesh Bhandari
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
Rx Mukul Sunil Tambe
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
Sujit Karpe
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
Subhash Yende
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
Dr. Ramesh Bhandari
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
RakibulHussain1
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
Irene Vadakkan
 
Prescription balkar ppt
Prescription balkar pptPrescription balkar ppt
Prescription balkar ppt
Rafi Bhat
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
Dr.Amreen Saba Attariya
 

What's hot (20)

Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
14ab1t0012 dispensing of narcotics and controlled substances
14ab1t0012   dispensing of narcotics and controlled substances14ab1t0012   dispensing of narcotics and controlled substances
14ab1t0012 dispensing of narcotics and controlled substances
 
14ab1 t0011 professional relations and practices of hospital pharmacy
14ab1 t0011  professional relations and practices of hospital pharmacy14ab1 t0011  professional relations and practices of hospital pharmacy
14ab1 t0011 professional relations and practices of hospital pharmacy
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
 
14ab1t0020 pharmacy and therapeutic committee
14ab1t0020   pharmacy and therapeutic committee14ab1t0020   pharmacy and therapeutic committee
14ab1t0020 pharmacy and therapeutic committee
 
Drug information final
Drug information finalDrug information final
Drug information final
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
 
Prescription balkar ppt
Prescription balkar pptPrescription balkar ppt
Prescription balkar ppt
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 

Similar to ward round participation.pptx

ward Round Participation.pptx
ward Round Participation.pptxward Round Participation.pptx
ward Round Participation.pptx
Anusha Are
 
Ward round participation
Ward round participationWard round participation
Ward round participation
Sarah Pulackal
 
2.b ward round participation
2.b ward round participation2.b ward round participation
2.b ward round participation
PARUL UNIVERSITY
 
Ward round participation
Ward round participationWard round participation
Ward round participation
Pooja Anothra
 
Ward round kosey
Ward round koseyWard round kosey
Ward round kosey
sopi_1234
 
anatomy and physiology of ward rounds
anatomy and physiology of ward rounds anatomy and physiology of ward rounds
anatomy and physiology of ward rounds
Pooja Panjwani
 
Clinical pharmacy.pptx
Clinical pharmacy.pptxClinical pharmacy.pptx
Clinical pharmacy.pptx
Alaa Fadhel Hassan Alwazni
 
Clinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal WardClinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal Ward
dhanvishah18
 
Clinical 1
Clinical 1Clinical 1
Clinical 1
Ashik Mosaddik
 
01 CHAPTER.pptx
01 CHAPTER.pptx01 CHAPTER.pptx
01 CHAPTER.pptx
Anusha Are
 
Atr implementar Implementation of the First Pharmacist Managed South Korea
Atr implementar Implementation of the First Pharmacist Managed South KoreaAtr implementar Implementation of the First Pharmacist Managed South Korea
Atr implementar Implementation of the First Pharmacist Managed South Korea
aresto
 
Patient safety & role of pharmacist
Patient safety & role of pharmacistPatient safety & role of pharmacist
Patient safety & role of pharmacist
Avinash Bhondwe
 
In patient care
In patient careIn patient care
In patient care
Naveed Sarwar
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
Clinical Pharmacy (CP)
Clinical Pharmacy (CP)Clinical Pharmacy (CP)
Clinical Pharmacy (CP)
SKarthigaSVCP
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
raviapr7
 
Define clinical pharmacy
Define clinical pharmacyDefine clinical pharmacy
Define clinical pharmacy
Rafi Bhat
 
medication adherence
medication adherencemedication adherence
medication adherence
Ramesh Ganpisetti
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
Ramesh Ganpisetti
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
KalloliChatterjee
 

Similar to ward round participation.pptx (20)

ward Round Participation.pptx
ward Round Participation.pptxward Round Participation.pptx
ward Round Participation.pptx
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
2.b ward round participation
2.b ward round participation2.b ward round participation
2.b ward round participation
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Ward round kosey
Ward round koseyWard round kosey
Ward round kosey
 
anatomy and physiology of ward rounds
anatomy and physiology of ward rounds anatomy and physiology of ward rounds
anatomy and physiology of ward rounds
 
Clinical pharmacy.pptx
Clinical pharmacy.pptxClinical pharmacy.pptx
Clinical pharmacy.pptx
 
Clinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal WardClinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal Ward
 
Clinical 1
Clinical 1Clinical 1
Clinical 1
 
01 CHAPTER.pptx
01 CHAPTER.pptx01 CHAPTER.pptx
01 CHAPTER.pptx
 
Atr implementar Implementation of the First Pharmacist Managed South Korea
Atr implementar Implementation of the First Pharmacist Managed South KoreaAtr implementar Implementation of the First Pharmacist Managed South Korea
Atr implementar Implementation of the First Pharmacist Managed South Korea
 
Patient safety & role of pharmacist
Patient safety & role of pharmacistPatient safety & role of pharmacist
Patient safety & role of pharmacist
 
In patient care
In patient careIn patient care
In patient care
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
 
Clinical Pharmacy (CP)
Clinical Pharmacy (CP)Clinical Pharmacy (CP)
Clinical Pharmacy (CP)
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Define clinical pharmacy
Define clinical pharmacyDefine clinical pharmacy
Define clinical pharmacy
 
medication adherence
medication adherencemedication adherence
medication adherence
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
 

More from Ameena Kadar

POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdfAPPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
Ameena Kadar
 
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONREVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
Ameena Kadar
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
Ameena Kadar
 
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxGENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
Ameena Kadar
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
Ameena Kadar
 
Pain pathways.pdf
Pain pathways.pdfPain pathways.pdf
Pain pathways.pdf
Ameena Kadar
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptx
Ameena Kadar
 
SCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxSCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptx
Ameena Kadar
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
Ameena Kadar
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptx
Ameena Kadar
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
Ameena Kadar
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
Ameena Kadar
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptx
Ameena Kadar
 
ALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdfALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdf
Ameena Kadar
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
Ameena Kadar
 
Responding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptxResponding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptx
Ameena Kadar
 
Anemia.pptx
Anemia.pptxAnemia.pptx
Anemia.pptx
Ameena Kadar
 
DIARRHEA.pdf
DIARRHEA.pdfDIARRHEA.pdf
DIARRHEA.pdf
Ameena Kadar
 
Investigational Product.
Investigational Product.Investigational Product.
Investigational Product.
Ameena Kadar
 

More from Ameena Kadar (20)

POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdfAPPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
 
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONREVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxGENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
 
Pain pathways.pdf
Pain pathways.pdfPain pathways.pdf
Pain pathways.pdf
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptx
 
SCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxSCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptx
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptx
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptx
 
ALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdfALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdf
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
 
Responding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptxResponding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptx
 
Anemia.pptx
Anemia.pptxAnemia.pptx
Anemia.pptx
 
DIARRHEA.pdf
DIARRHEA.pdfDIARRHEA.pdf
DIARRHEA.pdf
 
Investigational Product.
Investigational Product.Investigational Product.
Investigational Product.
 

Recently uploaded

KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
MiadAlsulami
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
salisonsalim1
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
fahmyahmed789
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi UniversitySuraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 

Recently uploaded (20)

KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
PET CT beginners Guide covers some of the underrepresented topics in PET CT
PET CT  beginners Guide  covers some of the underrepresented topics  in PET CTPET CT  beginners Guide  covers some of the underrepresented topics  in PET CT
PET CT beginners Guide covers some of the underrepresented topics in PET CT
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
Suraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi UniversitySuraj Goswami Journey From Guru Kashi University
Suraj Goswami Journey From Guru Kashi University
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 

ward round participation.pptx

  • 1. WARD ROUND PARTICIPATION AMEENA KADAR K A FIRST SEM M PHARM PHARMACY PRACTICE SANJO COLLEGE OF PHARMACEUTICAL STUDIES
  • 3. MEDICAL WARD ROUNDS  Ward rounds are the routine clinical rounds where the healthcare professionals (a doctor with or without a nurse, pharmacist, or any paramedical staff like technician or physiotherapist) visit the patients in the ward to assess the progress of the health condition of the inpatients.  At least one ward round is conducted every day to review the progress of each inpatient, although more than one is not uncommon.  It is also utilized as bedside teaching skills in a teaching hospital.
  • 4. Goals and Objectives of Clinical Pharmacists on Ward Rounds • Gain an improved understanding of the patient’s clinical status and progress, current planned investigations and therapeutic goals. • Provide relevant information on various aspects of the patient’s drug therapy, such as pharmacology, pharmacokinetics, drug availability, cost, drug interactions and adverse reactions • Optimize therapeutic management by influencing drug therapy selection, implementation, monitoring and follow-up • Investigate unusual drug orders or doses
  • 5. • Assimilate additional information about the patient such as comorbidities, medication compliance or complementary and alternative medicine (for example herbal remedies) use that might be relevant to their management • Detect adverse drug reactions and drug interactions • Participate in patient discharge planning.
  • 6. WARD ROUND CLASSIFICATION 1. Pre-ward rounds. 2. Registrar/resident rounds. 3. Professor/chief rounds. 4. Teaching ward rounds.
  • 7. PRE-ROUNDS  During these rounds, the interns or medical post-graduate students in teaching hospitals perform a daily review of patients in their unit or ward.  This is largely a learning opportunity to familiarize themselves with the cases, especially new admissions or transfers, and very few management decisions are made during these rounds.  Trainee clinical pharmacists may join the interns or postgraduates in their pre-rounds and complete the patient medication and clinical review at this time.
  • 8. REGISTRAR/RESIDENT ROUNDS  In teaching hospitals, the registrars and residents, individually or as a team conduct ward rounds, at least once a day at a fixed time, usually in the morning.  In the intensive care unit (ICU), rounds may be conducted several times a day.  These rounds are extensive and may also involve clinical teaching to medical postgraduate students and interns.  These are useful rounds for clinical pharmacists of all levels too.
  • 9. PROFESSOR/UNIT CHIEF ROUNDS  A ward round participation involving PG students, registrars, residents, and experienced doctors together is known as professor/chief rounds. It may be conducted daily, weekly, or monthly.  These types of ward rounds become extensive and specialized for discussing complex and complicated problems.  It may be difficult for clinical pharmacists to join these consultant rounds due to timing.
  • 10. TEACHING ROUNDS  In teaching hospitals, academic medical staff conducts bedside clinical teaching rounds for residents, medical PG students, interns, medical UG students, and Pharm D students.  It is usually extensive rounds and is conducted only a few times a week.  A clinical pharmacist can join during such rounds but will have limited exposure since this kind of ward rounds do not involve any kind of decision making and interventions.
  • 11. PRE-WARD ROUND PREPARATION • Pharmacists need to prepare adequately before participating in ward rounds. • Accurate and up to date information on the patient’s health status, disease management and past medical history is essential for effective participation in clinical decision making. • To achieve this a review of the medication chart and case record should be completed prior to the ward round. • Pre-ward round participation gives an overview of the drug and disease related issues that may arise during a ward round.
  • 12.  Many clinical pharmacists maintain individual patient profiles which summarize information relevant to the patient’s drug therapy. This includes:  Allergies or hypersensitivities  The reason for admission  Provisional or final diagnosis  Past medical history  Medications on admission  Relevant social history  laboratory data  Other relevant investigations and reports  Medication compliance
  • 14.  For all newly admitted patients, it is appropriate to collect a detailed medication history from the patient or their carers, which needs to be cross-checked with information collected by other healthcare professionals.  Any relevant new information obtained during the medication history interview which may change patient management (for example, history of allergy to a medicine) should be brought to the attention of the appropriate healthcare professionals and used to update existing patient profiles.  Pre-ward round preparation allows the pharmacist to be well informed and organized about the patient.
  • 15. Practical tips for ward round participation  Pharmacists should complete their pre-ward round preparation well ahead of commencement of the round.  Pharmacist should ensure that all prescriptions are in accordance with the hospital formulary.  Clinical pharmacists may wish to carry appropriate references while working in wards, Eg. BNF, up-to-date clinical guidelines, Drug Information Books., etc.  When identifying potential problems such as drug interactions, adverse reactions and medication errors, pharmacists should be prepared to suggest alternatives to resolve the problem.
  • 16.  Pharmacists should avoid the temptation to enter discussions concerning diagnosis. The one exception to this is where a patient’s symptoms or signs are possibly drug-related. Interventions during ward rounds A pharmacist intervention is defined as any action by a pharmacist that directly results in a change in patient management or therapy. Types: i. Active - Personal visits to influence prescribing ii. Passive - Drug information services iii. Reactive - Monitoring prescriptions
  • 17. The errors identified by the pharmacist included: o Incomplete orders o Wrong dose o Wrong frequency o Inappropriate choice o Duplicate therapy. The main drug-related queries that may arise during ward rounds relate to:  Dose and frequency  choice of medication  Adverse effects
  • 18.  Drug interactions  Formulation  Duration of therapy  Actions and uses/pharmacology  Drug availability/supply  Identification of patient’s medications on admission  legal and administrative issues  Miscellaneous, such as storage conditions
  • 19. Communication during ward rounds  Effective communication skills and clinical knowledge are pre- requisites for effective participation ward rounds.  Good interpersonal relationships are a key of success.  Learning of regional language helps the pharmacist to follow the conversation between the clinicians and the patients.  It also helps you to interact effectively with the patients.  Interventions or recommendations made by the pharmacist should be made in a diplomatic way, which shows respect for the physician’s clinical acumen and experience, and should not challenge a medical practitioner’s integrity.
  • 20. WARD ROUND FOLLOW-UP  Clinical pharmacists often encounter issues during a ward round that require some follow-up.  Some of the outstanding issues that may arise during a ward round include: 1. Responding to enquiries 2. Communicating information - changes in drug therapy 3. Completing documentation-ADRs identified during the round may need to be documented on an alert sheet. 4. Altering the patient’s care plan 5. Discussions with patients - the reasons for alteration in therapy, drug administration or self monitoring techniques and caution regarding likely adverse effects
  • 21. REFERENCES 1. A Textbook of Clinical Pharmacy, Essential concepts and Skills by G Parthasarathy, Karin Nyfort-Hansen, Milap C Nahata. 2nd Edition. Pg No:211- 221. 2. https://www.14impressions.in/2020/12/goals- classification-interventions-and.html#point0
  • 22. HAVE A GOOD DAY!